Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for Asthma Patients — AsthmaTrain  

Asthma Clinical Trial

Official title: Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for Asthma Patients

Status Completed

Clinical Trial Summary

The onset of smartphone usage has provided new opportunities for managing patients outside the walls of healthcare facilities. The development of asthma-specific smartphone applications represents an excellent area for partnership between developers and medical teams for delivering therapeutic education at the required time and in a personalised way. Within this context, the overall goal of the AsthmaTrain study is to perform a first, small pilot study comparing a new French-language chat-bot guided asthma patient education programme (the 'Vik' application) with the classic, authority-approved patient education program at the University Hospitals of Montpellier, Montpellier, France.

The primary objective is to compare a population of adult patients with asthma and participating in a standard patient education programme with a similar population participating in Vik-guided education programme in terms of change in overall scores on the Asthma Quality of Life Questionnaire (AQLQ).

Clinical Trial Description

Secondarily, the following will also be compared between the two study arms:

• the subdomains of the AQLQ score,

• lung function, overall asthma control and exacerbation rates,

• general health status via the Euroqol 5-domain 5-level questionnaire (EQ-5D-5L),

• adherence to the program and burden of the program for the medical team,

• major categories of direct health resource consumption.

Finally, because education intervention success may depend on patient-specific characteristics, an ancillary study will compare the following baseline traits between the 50% best intervention responders in either arm:

• the big five personality traits,

• the hospital anxiety and depression,

• coping mechanisms. ;

Related Conditions & MeSH terms

• Asthma

• NCT number: NCT05248126
• Study type: Interventional
• Source: University Hospital, Montpellier
• Status: Completed
• Phase: N/A
• Start date: May 24, 2022
• Completion date: October 27, 2023